4-Fluorodeprenyl
| Clinical data | |
|---|---|
| Other names | p-F-Depreny; Fludeprenyl; N-Methyl-N-propargyl-4-fluoroamphetamine; N-Propargyl-4-fluoromethamphetamine; N-Propargyl-4-FMA |
| Drug class | Stimulant; Monoamine oxidase inhibitor; MAO-B inhibitor |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H16FN |
| Molar mass | 205.276 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-Fluorodeprenyl, or p-F-deprenyl, also known as fludeprenyl or as N-methyl-N-propargyl-4-fluoroamphetamine, is a stimulant and monoamine oxidase inhibitor (MAOI) of the amphetamine family.[1][2][3][4] It is the 4-fluoro derivative of deprenyl and the racemic form of 4-fluoroselegiline.[3][4][2] The drug is metabolized into the stimulants 4-fluoroamphetamine (4-FA) and 4-fluoromethamphetamine (4-FMA) and hence acts in part as a prodrug of these metabolites.[3][4][1][2] Accordingly, it produces methamphetamine-like effects in drug discrimination tests in squirrel monkeys.[1][2] Like deprenyl and selegiline (L-deprenyl), 4-fluorodeprenyl is additionally a selective and irreversible inhibitor of monoamine oxidase B (MAO-B).[4] The drug was encountered as a novel designer drug in Germany in 2019.[4]
See also
References
- ^ a b c Kirk KL, Yoshida S, Haufe G (2008). "Synthesis and Biochemical Evaluation of Fluorinated Monoamine Oxidase Inhibitors". Fluorine and Health. Elsevier. pp. 661–697. doi:10.1016/b978-0-444-53086-8.00015-1. ISBN 978-0-444-53086-8. Retrieved 1 January 2026.
- ^ a b c d Yasar S, Gaal J, Justinova Z, Bergman J (October 2005). "Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys". Psychopharmacology. 182 (1): 95–103. doi:10.1007/s00213-005-0063-y. PMID 15990999. S2CID 444126.
- ^ a b c "п-Фтордепренил (p-F-Deprenyl)". АИПСИН (in Russian). Retrieved 1 January 2026.
- ^ a b c d e "п-Фтордепренил (4F-deprenyl)". АИПСИН (in Russian). Retrieved 1 January 2026.
External links
| Non-specific |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phenethylamines (dopamine, epinephrine, norepinephrine) |
| ||||||||||
| Tryptamines (serotonin, melatonin) |
| ||||||||||
| Histamine |
| ||||||||||
See also: Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins | |||||||||||
| Endogenous | |
|---|---|
| Synthetic |
|
| Antagonists | |
See also: Receptor/signaling modulators • Monoamine releasing agents • Monoamine reuptake inhibitors • Monoamine metabolism modulators • TAAR ligands | |
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
| |||||||||||||||||